Law firm investigates GeneDx after shares plunge 50% on weak earnings and lowered guidance
Bragar Eagel & Squire, P.C. is investigating GeneDx Holdings Corp. following the company's Q1 2026 report showing a $57.5 million loss and a 50% drop in share price. GeneDx lowered its 2026 revenue forecast by $65 million due to weaker reimbursement ...
